Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study

被引:122
|
作者
Sinn, Dong Hyun [1 ]
Kang, Danbee [2 ]
Jang, Hye Ryoun [1 ]
Gu, Seonhye [3 ]
Cho, Soo Jin [4 ]
Paik, Seung Woon [1 ]
Ryu, Seungho [5 ]
Chang, Yoosoo [5 ]
Lazo, Mariana [6 ,7 ,8 ]
Guallar, Eliseo [3 ,6 ,7 ,8 ]
Cho, Juhee [2 ,3 ,6 ,7 ,8 ]
Gwak, Geum-Youn [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, 81 Irwon Ro, Seoul 06351, South Korea
[2] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, 81 Irwon Ro, Seoul 06351, South Korea
[3] Sungkyunkwan Univ, Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea
[4] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea
[5] Kangbuk Samsung Hosp, Ctr Total Hlth Studies, Seoul, South Korea
[6] Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA
[7] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA
[8] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA
关键词
Chronic kidney disease; Cohort; Fatty liver; Liver fibrosis; VITAMIN-D-RECEPTOR; HEPATIC STEATOSIS; FIBROSIS; PREVALENCE; NAFLD; RISK; MECHANISMS; HISTOLOGY;
D O I
10.1016/j.jhep.2017.08.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Non-alcoholic fatty liver disease (NAFLD) has been associated with chronic kidney disease (CKD), but cohort studies are limited. We investigated the longitudinal association of NAFLD and its severity with the development of CKD. Methods: We performed a retrospective cohort study of 41,430 adult men and women (average age, 48.9 y) without CKD at baseline who underwent repeated health check-up examinations from January 1, 2003, through December 31, 2013. NAFLD status was assessed by ultrasonography, and NAFLD severity was assessed by the NAFLD fibrosis score (NFS). Results: The outcome was an incident CKD, defined as an estimated glomerular filtration rate less than 60 ml/min/1.73 m(2). During 200,790 person-years of follow-up (median follow-up of 4.15 years), we identified 691 incident CKD cases. The multivariable-adjusted hazard ratio for CKD comparing participants with and without NAFLD was 1.22 (95% confidence interval [CI] 1.04-1.43). The risk of CKD increased progressively with increased NAFLD severity. The multivariable-adjusted hazard ratios for CKD comparing participants with NFS < - 1.455 and those with NFS >= - 1.455 to participants without NAFLD were 1.09 (95% CI 0.91-1.32) and 1.58 (95% CI 1.30-1.92), respectively. The association was consistent across clinically relevant subgroups. Conclusion: In a large cohort of adult men and women without CKD, NAFLD was associated with an increased risk of CKD development. NAFLD may adversely affect renal function and patients may need to be carefully monitored for an increased risk of CKD. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1274 / 1280
页数:7
相关论文
共 50 条
  • [41] Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Mehmet Kanbay
    Mustafa C. Bulbul
    Sidar Copur
    Baris Afsar
    Alan A. Sag
    Dimitrie Siriopol
    Masanari Kuwabara
    Silvia Badarau
    Adrian Covic
    Alberto Ortiz
    Journal of Nephrology, 2021, 34 : 649 - 659
  • [42] Cardiovascular disease in patients with non-alcoholic fatty liver disease
    Kantartzis, Konstantinos
    Stefan, Norbert
    ANNALS OF GASTROENTEROLOGY, 2012, 25 (03): : 276 - 277
  • [43] Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study
    Akahane, Takemi
    Akahane, Manabu
    Namisaki, Tadashi
    Kaji, Kosuke
    Moriya, Kei
    Kawaratani, Hideto
    Takaya, Hiroaki
    Sawada, Yasuhiko
    Shimozato, Naotaka
    Fujinaga, Yukihisa
    Furukawa, Masanori
    Kitagawa, Koh
    Ozutsumi, Takahiro
    Tsuji, Yuki
    Kaya, Daisuke
    Mitoro, Akira
    Yoshiji, Hitoshi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [44] Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Yamamura, Sakura
    Nakano, Dan
    Hashida, Ryuki
    Tsutsumi, Tsubasa
    Kawaguchi, Takumi
    Okada, Michiaki
    Isoda, Hiroshi
    Takahashi, Hirokazu
    Matsuse, Hiroo
    Eguchi, Yuichiro
    Sumida, Yoshio
    Nakajima, Atsushi
    Gerber, Lynn
    Younossi, Zobair M.
    Torimura, Takuji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (03) : 629 - 636
  • [45] Genetic Background of Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease Patients
    Kogiso, Tomomi
    Sagawa, Takaomi
    Kodama, Kazuhisa
    Taniai, Makiko
    Tokushige, Katsutoshi
    HEPATOLOGY, 2018, 68 : 1297A - 1298A
  • [46] Non-Alcoholic Fatty Liver Disease In Chronic Obstructive Pulmonary Disease
    Viglino, D.
    Jullian-Desayes, I.
    Minoves, M.
    Aron-Wisnewsky, J.
    Leroy, V.
    Zarski, J. P.
    Tamisier, R.
    Joyeux-Faure, M.
    Pepin, J. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [47] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [48] Statin use on development and progression of non-alcoholic fatty liver disease: A nationwide cohort study
    Lee, Jung Il
    Lee, Kwan Sik
    Lee, Hyun Woong
    Chang, Hye Young
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E302 - E302
  • [49] Liver disease severity and risk of kidney damage in patients with non-alcoholic fatty liver disease (NAFLD)
    Agrawal, Saurabh
    Lopez, Rocio
    Omo, Jason T.
    Conjeevaram, Hari S.
    GASTROENTEROLOGY, 2008, 134 (04) : A784 - A784
  • [50] Risk for the development of non-alcoholic fatty liver disease: A prospective study
    Wang, Jinghua
    Ma, Liang
    Chen, Shenghui
    Xu, Lei
    Miao, Min
    Yu, Chaohui
    Li, Youming
    Xu, Chengfu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (08) : 1518 - 1523